Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Sujobert

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Molecular Diagnostics : JMD|April 15, 2022
Panel Informativity Optimizer: An R Package to Improve Cancer Next-Generation Sequencing Panel InformativityVincent Alcazer, Pierre Sujobert
Blood|July 29, 2017
Morphologic features of μ-heavy-chain diseaseLucien Courtois, Pierre Sujobert
Molecular & Cellular Oncology|September 22, 2016
Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemiaPierre Sujobert, Jerome Tamburini
British Journal of Haematology|September 27, 2007
Images in haematology. Bilateral adrenal chloromasPierre Sujobert, Valérie Bardet, Marie Bienvenu
Nature Reviews. Cancer|February 10, 2018
From genetics to the clinic: a translational perspective on follicular lymphomaSarah Huet, Pierre Sujobert, Gilles Salles
Hematology/Oncology Clinics of North America|November 28, 2016
Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?Pierre Sujobert, Gilles Salles, Emmanuel Bachy
Current Opinion in Hematology|February 2, 2023
VEXAS: where do we stand 2 years later?Pierre Sujobert, Maël Heiblig, Yvan Jamilloux
The Lancet. Haematology|March 5, 2025
Epistemic limitations of measurable residual disease in haematological malignanciesBenjamin Chin-Yee, Lucie Laplane, Pierre Sujobert
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Idelalisib: Targeting the PI3 Kinase Pathway in Non-Hodgkin LymphomaPierre Sujobert, Catherine Rioufol, Gilles A Salles
Ejhaem|January 27, 2025
What is the origin of the normal ranges of blood cell counts? An evolutionary perspectiveManon Zala, Vincent Alcazer, Laetitia Largeaud, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Molecular Diagnostics : JMD|April 15, 2022
Panel Informativity Optimizer: An R Package to Improve Cancer Next-Generation Sequencing Panel InformativityVincent Alcazer, Pierre Sujobert
Blood|July 29, 2017
Morphologic features of μ-heavy-chain diseaseLucien Courtois, Pierre Sujobert
Molecular & Cellular Oncology|September 22, 2016
Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemiaPierre Sujobert, Jerome Tamburini
British Journal of Haematology|September 27, 2007
Images in haematology. Bilateral adrenal chloromasPierre Sujobert, Valérie Bardet, Marie Bienvenu
Nature Reviews. Cancer|February 10, 2018
From genetics to the clinic: a translational perspective on follicular lymphomaSarah Huet, Pierre Sujobert, Gilles Salles
Hematology/Oncology Clinics of North America|November 28, 2016
Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?Pierre Sujobert, Gilles Salles, Emmanuel Bachy
Current Opinion in Hematology|February 2, 2023
VEXAS: where do we stand 2 years later?Pierre Sujobert, Maël Heiblig, Yvan Jamilloux
The Lancet. Haematology|March 5, 2025
Epistemic limitations of measurable residual disease in haematological malignanciesBenjamin Chin-Yee, Lucie Laplane, Pierre Sujobert
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Idelalisib: Targeting the PI3 Kinase Pathway in Non-Hodgkin LymphomaPierre Sujobert, Catherine Rioufol, Gilles A Salles
Ejhaem|January 27, 2025
What is the origin of the normal ranges of blood cell counts? An evolutionary perspectiveManon Zala, Vincent Alcazer, Laetitia Largeaud, et al.
Pageof 13